An event of embolization of a device implanted in 2013 and off label use of a cribriform device to close a pfo was reported.The results of the investigation are inconclusive since the device remains implanted was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.Please note, per the instructions for use, artmt 600218-010 revision b "contraindications: treatment of patients with patent foramen ovale (pfo) defects.This device has not been studied in patients with pfo defects.".
|
On an unknown date in 2013, a 18mm amplatzer asd mf occluder was implanted for a pfo.On an unknown date, the device embolized.There was no indication as to the time frame of the embolization.At the start of the procedure, the device was observed to be in the descending aorta under fluoroscopy.Access was gained via the femoral artery and a 6f gooseneck snare was used to grasp the embolized device.It was then observed under fluoroscopy that the device had epithelialized within the descending aorta tissues and removal of the 18mm asd mf was aborted.The pfo was closed using a 35mm pfo occluder successfully.
|